Lanean...
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances
Type 1 diabetes (T1D) results from the progressive destruction of pancreatic β-cells in a process mediated primarily by T lymphocytes. The T1D research community has made dramatic progress in understanding the genetic basis of the disease as well as in the development of standardized autoantibody as...
Gorde:
| Argitaratua izan da: | Diabetes |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Diabetes Association
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609980/ https://ncbi.nlm.nih.gov/pubmed/31221801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0119 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|